Back
Novo Nordisk A/S Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
NVO
Novo Nordisk A/S
Last Price:
$49.50
Seasonality Move:
10.96%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
Novo Nordisk A/S Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.08 | Buy |
| 20-day SMA: | 55.67 | Sell |
| 50-day SMA: | 53.26 | Sell |
| 200-day SMA: | 58.32 | Sell |
| 8-day EMA: | 49.98 | Sell |
| 20-day EMA: | 52.96 | Sell |
| 50-day EMA: | 53.61 | Sell |
| 200-day EMA: | 60.68 | Sell |
Novo Nordisk A/S Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.07 | Sell |
| Relative Strength Index (14 RSI): | 40.15 | Sell |
| Chaikin Money Flow: | -1981439 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.35 - 62.29) | Sell |
| Bollinger Bands (100): | (47.89 - 58.17) | Sell |
Novo Nordisk A/S Technical Analysis
| Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Novo Nordisk A/S Stock
Is Novo Nordisk A/S Stock a Buy?
-
Novo Nordisk A/S share price is 48.93 while NVO 8-day simple moving average is 48.08, which is a Buy signal.
-
The stock price of NVO is 48.93 while Novo Nordisk A/S 20-day SMA is 55.67, which makes it a Sell.
-
Novo Nordisk A/S 50-day simple moving average is 53.26 while NVO share price is 48.93, making it a Sell technically.
-
NVO stock price is 48.93 and Novo Nordisk A/S 200-day simple moving average is 58.32, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
30
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a SellThe current Novo Nordisk A/S [NVO] share price is $48.93. The Score for NVO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk A/S Stock Info
Market Cap:
217.6B
Price in USD:
48.93
Share Volume:
11.7M
Novo Nordisk A/S 52-Week Range
52-Week High:
93.80
52-Week Low:
43.08
Sell
30
Novo Nordisk A/S (NVO)
is a Sell
Novo Nordisk A/S Share Price Forecast
-
What is the Novo Nordisk A/S stock price today?The Novo Nordisk A/S stock price is 48.93 USD today.
-
Will NVO stock go up or go down?Novo Nordisk A/S> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk A/S overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk A/S is overvalued.
Is Novo Nordisk A/S Stock a Buy?
-
Novo Nordisk A/S share price is 48.93 while NVO 8-day exponential moving average is 49.98, which is a Sell signal.
-
The stock price of NVO is 48.93 while Novo Nordisk A/S 20-day EMA is 52.96, which makes it a Sell.
-
Novo Nordisk A/S 50-day exponential moving average is 53.61 while NVO share price is 48.93, making it a Sell technically.
-
NVO stock price is 48.93 and Novo Nordisk A/S 200-day simple moving average is 60.68, creating a Sell signal.
Fundamental Analysis of Novo Nordisk A/S
Is Novo Nordisk A/S a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $142.44 per share, and an increase next year of $0.06 per share.
Technical Analysis of Novo Nordisk A/S
Should I short Novo Nordisk A/S stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -2.07, suggesting Novo Nordisk A/S is a Sell
-
Novo Nordisk A/S Relative Strength Index (RSI) is 40.15, which suggest Novo Nordisk A/S is oversold
-
The Bollinger Bands (25) for Novo Nordisk A/S is (50.35 - 62.29), which suggest Novo Nordisk A/S is a Sell
-
The Bollinger Bands (100) for Novo Nordisk A/S is (47.89 - 58.17), which suggest Novo Nordisk A/S is a Sell
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.